“Is the Compulsory Licensing Mechanism Guaranteed by TRIPS the Best Remedy to Improve Access to Biological Therapies Worldwide?” (2019) Eastern European Journal of Transnational Relations, 3(1), pp. 39–52. doi:10.15290/eejtr.2019.03.01.03.